BSECorp. Action7h ago · 25 Sept 2026, 11:25 am
Intimation of Record Date for Rights Issue
Natco Pharma Ltd · 524816
✦ AI SummaryFundraise
Natco Pharma Ltd has announced the record date for its rights issue, set as Thursday, 1st October, 2026, to determine the shareholders eligible to receive the rights entitlements.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Natco Pharma Ltd - 524816 - Intimation Of Record Date For Rights Issue
Attachments (1)
📄pdf
Download →
ed4dcbeb-1059-409d-b096-2739a4b87033.pdf
View document text
September 25, 2026
Corporate Relationship Department The Manager – Listing
M/s. BSE Ltd. M/s. National Stock Exchange of India Ltd.
Mumbai – 400 001. MUMBAI – 400 051.
Scrip Code: 524816 Scrip Code: NATCOPHARM
Sub:- Intimation of record date pursuant to Regulation 42 of SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015
Ref: Outcome of the Board meeting intimated vide letter dated September 25, 2026
Dear Sir/Madam,
Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, we wish to inform you that the Board of Directors of the Company at
their meeting held today has fixed the Record date for the Rights Issue of the equity shares
as Thursday, 1st October, 2026 to determine the shareholders who will be eligible to
receive the Rights Entitlements under the Rights Issue.
Kindly take the same on record.
Thanking you
Yours faithfully,
For NATCO Pharma Limited
Ch. Venkat Ramesh
Company Secretary &
Compliance Officer